SCINOVO is a unique, inter-disciplinary organization dedicated to providing integrated preclinical development solutions and support to our preferred partners, from discovery through commercialization. SCINOVO offers onepoint^sm access to the global scientific resources and regulatory expertise of GSK, channeling best practices, best pricing, and highest service quality into each development collaboration.

If you are interested in how GSK and SCINOVO could help you make the most of your preclinical asset, click here for the Business Development contact page